Actively Recruiting
Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
Led by Han Joo Lee · Updated on 2024-12-12
84
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
Sponsors
H
Han Joo Lee
Lead Sponsor
P
Psi Chi
Collaborating Sponsor
AI-Summary
What this Trial Is About
Thought-Action-Fusion (TAF) is a cognitive bias that posits (1) having unwanted thoughts is morally equivalent to acting upon the thoughts (TAF-Moral; e.g., "Thinking about harming a child is as immoral as actually harming a child") and (2) having unwanted thoughts will increase the likelihood of the thoughts happening in real life (TAF-Likelihood; e.g., "My mother will get into a car accident, because I thought about it"). Given its central role in the development and maintenance of OCD, TAF has emerged as a potential treatment target for obsessive-compulsive disorder (OCD). Previous research has demonstrated that TAF is indeed a malleable construct. This study aims to examine the effects of a multi-session, personalized cognitive bias modification (CBM) for thought-action-fusion (TAF) on improving obsessive-compulsive (OC) symptoms in a college sample.
CONDITIONS
Official Title
Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Score of 18 or higher on the Dimensional Obsessive-Compulsive Scale (DOCS)
- Age 18 years or older
- Access to a mobile device such as a smartphone
You will not qualify if you...
- Visual impairment that cannot be corrected and prevents clear recognition of words and pictures on a mobile screen
- History of bipolar disorder or psychotic disorder as self-reported on a Diagnostic History Scale
- Inability to understand study procedures based on responses to comprehension questions at consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UWM Anxiety Disorders Laboratory
Milwaukee, Wisconsin, United States, 53211
Actively Recruiting
Research Team
H
Hanjoo Lee, PhD
CONTACT
M
Minjee Kook, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here